Triple

T10291880
Position Surface form Disambiguated ID Type / Status
Subject BCRP E241383 entity
Predicate substrateOf P37222 FINISHED
Object rosuvastatin
Rosuvastatin is a statin medication used to lower cholesterol and reduce cardiovascular risk by inhibiting HMG-CoA reductase.
 E852341 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: rosuvastatin | Statement: [BCRP, substrateOf, rosuvastatin]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: rosuvastatin
Context triple: [BCRP, substrateOf, rosuvastatin]
  • A. Lipitor
    Lipitor is a widely prescribed statin medication used to lower cholesterol and reduce the risk of cardiovascular disease.
  • B. Zetia
    Zetia is a prescription cholesterol-lowering medication (generic name ezetimibe) that reduces intestinal absorption of cholesterol and is marketed by Merck & Co.
  • C. Brilinta
    Brilinta is a prescription antiplatelet medication (ticagrelor) used to reduce the risk of heart attack, stroke, and cardiovascular death in patients with acute coronary syndrome or a history of myocardial infarction.
  • D. Entresto
    Entresto is a prescription heart failure medication that combines sacubitril and valsartan to reduce the risk of cardiovascular death and hospitalization.
  • E. Waylivra
    Waylivra is a prescription antisense oligonucleotide therapy used to treat familial chylomicronemia syndrome (FCS) by reducing triglyceride levels in the blood.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: rosuvastatin
Triple: [BCRP, substrateOf, rosuvastatin]
Generated description
Rosuvastatin is a statin medication used to lower cholesterol and reduce cardiovascular risk by inhibiting HMG-CoA reductase.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: rosuvastatin
Target entity description: Rosuvastatin is a statin medication used to lower cholesterol and reduce cardiovascular risk by inhibiting HMG-CoA reductase.
  • A. Lipitor
    Lipitor is a widely prescribed statin medication used to lower cholesterol and reduce the risk of cardiovascular disease.
  • B. Zetia
    Zetia is a prescription cholesterol-lowering medication (generic name ezetimibe) that reduces intestinal absorption of cholesterol and is marketed by Merck & Co.
  • C. Brilinta
    Brilinta is a prescription antiplatelet medication (ticagrelor) used to reduce the risk of heart attack, stroke, and cardiovascular death in patients with acute coronary syndrome or a history of myocardial infarction.
  • D. Entresto
    Entresto is a prescription heart failure medication that combines sacubitril and valsartan to reduce the risk of cardiovascular death and hospitalization.
  • E. Waylivra
    Waylivra is a prescription antisense oligonucleotide therapy used to treat familial chylomicronemia syndrome (FCS) by reducing triglyceride levels in the blood.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d381aaafc08190af475ef58dc16aba completed April 6, 2026, 9:49 a.m.
NER Named-entity recognition batch_69d4dfbfa26c8190b536655d33112ddf completed April 7, 2026, 10:43 a.m.
NED1 Entity disambiguation (via context triple) batch_69d6f85dcbac8190a2ac66354010e328 completed April 9, 2026, 12:52 a.m.
NEDg Description generation batch_69d6fcaee26c8190a19f7d07a63531f6 completed April 9, 2026, 1:11 a.m.
NED2 Entity disambiguation (via description) batch_69d6fd879ab88190b0a47295f5d7ad4d completed April 9, 2026, 1:14 a.m.
Created at: April 6, 2026, 11:42 a.m.